|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 11400 TOMAHAWK CREEK PARKWAY |
Address2 |
|
City | LEAWOOD |
State | KS |
Zip Code | 66211-2672 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 1342-12
|
||||||||
|
6. House ID# 321800000
|
TYPE OF REPORT | 8. Year | 2019 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Lisa R. Westergaard |
Date | 10/21/2019 3:49:44 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
S106; S192; HR1943; HR1983; HR 2328, - National Health Service Corps: Medical Student Debt Relief and Rural and Under-served area access.
S 304; HR 2815; HR 2328 - Teaching Health Center GME Re-authorization: Increased, extended THCGME funding.
HR 1358 - GME Reform: Allow the establishment of new family physician residencies.
HR 2740 - HHS FY 2020 Appropriations; Women's Health Research: AAFP funding priorities. Increased funding for women's health research.
HR 3030 - Patient Centered Outcomes Research Institute reauthorization: Patient-centered, primary care research, AHRQ funding.
No Bill No. - Obesity Drug Study: Responding to GAO inquiry on AAFP policy on obesity drugs.
No Bill No. - Rural Health: Improved access to quality care for rural populations.
No Bill No. - Teaching Health Center GME funding/Training the Next Generation of Primary Care Doctors Act.
No Bill No. - Title VII Primary Care training Enhancement Grants: Support for family medicine training.
No Bill No. - AHRQ Center for Primary Care Research: Primary Care research at AHRQ.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Government Accountability Office (GAO)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Teresa |
Baker |
|
House Legislative Assistant, Analyst, and Director |
|
Mark |
Cribben |
|
|
|
Sonya |
Clay |
|
Legislative Assistant, Office of U.S. Rep. Jose Serrano; Legislative Assistant, Office of U.S. Rep. Steny Hoyer; Legislative Director, Office of U.S. Rep. Barbara Lee; Legislative Assistant, Office of U.S. Rep.Glen Browder |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code EDU
16. Specific lobbying issues
S106; S192; HR1943; HR1983; HR 2328, - National Health Service Corps: Medical Student Debt Relief and Rural and Under-served area access.
S 289 - Rural Physician Workforce Protection Act: GME reform to support rural residency training.
S 304; HR 2815; HR 2328 - Teaching Health Center GME Re-authorization: Increased, extended THCGME funding.
S 2372 Rural Moms Act: Supported a rural maternal health bill and urged members to support it.
HR 1358 - GME Reform: Allow the establishment of new family physician residencies.
HR 2328 Community Health Investment, and Modernization, and Excellence Act: Also, THCGME, along with Community Health Centers, National Health Service Corps, and Medicaid Funding for the Territories.
HR 2328 - Reauthorizing and Extending America's Community Health Act: Support for key primary care extenders, Patient-Centered Outcomes Research Initiative, Independence at Home, Medicaid for the Territories.
HR 2895 - Conrad State 30 & Physician Access Act: Expand J-1 visa waiver program for medical residents.
No Bill No. - Opioid Use Disorder Treatment GME: Medication-assisted treatment training.
No Bill No. - Physician Workforce/GME Reform: Increasing the number of family residency slots.
No Bill No. - Congressional Primary Care Caucus: 116th Congress Membership in the bipartisan CPCC.
No Bill No. - Teaching Health Center GME funding/Training the Next Generation of Primary Care Doctors Act.
No Bill No. - Congressional Primary Care Caucus: 116th Congress Membership in the bipartisan CPCC.
No Bill No. - Title VII Primary Care training Enhancement Grants: Support for family medicine training.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Mark |
Cribben |
|
|
|
Teresa |
Baker |
|
House Legislative Assistant, Analyst, and Director |
|
Sonya |
Clay |
|
Legislative Assistant, Office of U.S. Rep. Jose Serrano; Legislative Assistant, Office of U.S. Rep. Steny Hoyer; Legislative Director, Office of U.S. Rep. Barbara Lee; Legislative Assistant, Office of U.S. Rep.Glen Browder |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
S106; S192; HR1943; HR1983; HR 2328, - National Health Service Corps: Medical Student Debt Relief and Rural and Under-served area access.
S 289 - Rural Physician Workforce Protection Act: GME reform to support rural residency training.
S 304; HR 2815; HR 2328 - Teaching Health Center GME Re-authorization: Increased, extended THCGME funding.
S 2372 Rural Moms Act: Supported a rural maternal health bill and urged members to support it.
HR 2328 Community Health Investment, and Modernization, and Excellence Act: Also, THCGME, along with Community Health Centers, National Health Service Corps, and Medicaid Funding for the Territories.
HR 2328 - Reauthorizing and Extending America's Community Health Act: Support for key primary care extenders, Patient-Centered Outcomes Research Initiative, Independence at Home, Medicaid for the Territories.
HR 2740 - HHS FY 2020 Appropriations; Women's Health Research: AAFP funding priorities. Increased funding for women's health research.
HR 2774 - Primary Care Patient Protection Act: Create a Primary Care benefit in high deductible health plans.
HR 2895 - Conrad State 30 & Physician Access Act: Expand J-1 visa waiver program for medical residents.
HR 3030 - Patient Centered Outcomes Research Institute reauthorization: Patient-centered, primary care research, AHRQ funding.
HR 3107 - Prior Authorization: Improve healthcare access and reduce administrative burden.
HR 3436 - Chronic Care Management: to remove cost-sharing responsibilities for chronic care management services under the medicare plan.
No Bill No. - Obesity Drug Study: Responding to GAO inquiry on AAFP policy on obesity drugs.
No Bill No. - Opioid prescribing guideline: Responding to FDA inquiry on opioid prescribing guidelines.
No Bill No. - Healthcare Coverage for All: Retaining ACA coverage gains and expanding coverage.
No Bill No. - Administrative Burden: Reduced administrative burden on family physicians.
No Bill No. - Rural Health: Improved access to quality care for rural populations.
No Bill No. - Primary Care Investment: Increased spending on primary care.
No Bill No. - Congressional Primary Care Caucus: 116th Congress Membership in the bipartisan CPCC.
No Bill No. - Insurance network adequacy to avoid "surprise medical bills": protecting patients and families from unanticipated medical bills.
No Bill No. - Comment on the definition of Health Literacy: Health Literacy for all patients.
No Bill No. - Administrative Simplification: Suggestions to reduce burdens for FPs.
No Bill No. - Nondiscrimination in health plans: Healthcare for all.
No Bill No. - Patient access to effective drugs: Opioid Issues.
No. Bill No. - Telehealth for low-income consumers: Access to high speed internet.
No Bill No. - Access to Medicaid Services: Need for higher payment to ensure access to primary care.
No Bill No. - 2020 proposed outpatient perspective payment system: Site of service neutrality and transparency in hospital charges.
No Bill No. - Lower Health Care Costs Act/Surprise Billing: Support for vaccines, maternal health, transparency, and reducing administrative burdens. Also, support for reauthorizing the Teaching Health Center GME (THCGME) program, along with Community Health Centers and National Health Service Corps.
No Bill No. - Teaching Health Center GME funding/Training the Next Generation of Primary Care Doctors Act.
No Bill No. - Tobacco Use Prevention: Urged support for Reversing the Youth Tobacco Epidemic Act, Safe Kids Act, and Tobacco to 21 bill.
No Bill No. - Surprise Billing: Shared letter on surprise billing.
No Bill No. - Drug Prices: Recommendations for various biologic and insulin drug pricing bills.
No Bill No. - Congressional Primary Care Caucus: 116th Congress Membership in the bipartisan CPCC.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Government Accountability Office (GAO), Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Mark |
Cribben |
|
|
|
Teresa |
Baker |
|
House Legislative Assistant, Analyst, and Director |
|
Sonya |
Clay |
|
Legislative Assistant, Office of U.S. Rep. Jose Serrano; Legislative Assistant, Office of U.S. Rep. Steny Hoyer; Legislative Director, Office of U.S. Rep. Barbara Lee; Legislative Assistant, Office of U.S. Rep.Glen Browder |
|
Robert |
Bennett |
|
Health Insurance Specialist , CMS Office of Communication |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
S106; S192; HR1943; HR1983; HR 2328, - National Health Service Corps: Medical Student Debt Relief and Rural and Under-served area access.
S 289 - Rural Physician Workforce Protection Act: GME reform to support rural residency training.
HR 1358 - GME Reform: Allow the establishment of new family physician residencies.
HR 2328 Community Health Investment, and Modernization, and Excellence Act: Also, THCGME, along with Community Health Centers, National Health Service Corps, and Medicaid Funding for the Territories.
HR 2328 - Reauthorizing and Extending America's Community Health Act: Support for key primary care extenders, Patient-Centered Outcomes Research Initiative, Independence at Home, Medicaid for the Territories.
HR 3107 - Prior Authorization: Improve healthcare access and reduce administrative burden.
HR 3436 Chronic Care Management: to remove cost-sharing responsibilities for chronic care management services under the medicare plan.
No Bill No. - Opioid prescribing guideline: Responding to FDA inquiry on opioid prescribing guidelines.
No Bill No. - Opioid Use Disorder Treatment GME: Medication-assisted treatment training.
No Bill No. - Physician Workforce/GME Reform: Increasing the number of family residency slots.
No Bill No. - Administrative Burden: Reduced administrative burden on family physicians.
No Bill No. - Primary Care Investment: Increased spending on primary care.
No Bill No. - Congressional Primary Care Caucus: 116th Congress Membership in the bipartisan CPCC.
No Bill No. - Insurance network adequacy to avoid "surprise medical bills": protecting patients and families from unanticipated medical bills.
No Bill No. - Administrative Simplification: Suggestions to reduce burdens for FPs.
No Bill No. - Medicare coverage of acupuncture: AAFP supporting CMS proposal.
No Bill No. - Access to Medicaid Services: Need for higher payment to ensure access to primary care.
No Bill No. - Delay in 2017 APM bonuses: Need for CMS to pay APM bonuses to encourage FPs.
No Bill No. - 2020 proposed Medicare physician fee schedule: Payments to PCPs.
No Bill No. - 2020 proposed outpatient perspective payment system: Site of service neutrality and transparency in hospital charges.
No Bill No. - Lower Health Care Costs Act/Surprise Billing: Support for vaccines, maternal health, transparency, and reducing administrative burdens. Also, support for reauthorizing the Teaching Health Center GME (THCGME) program, along with Community Health Centers and National Health Service Corps.
No Bill No. - Congressional Primary Care Caucus: 116th Congress Membership in the bipartisan CPCC.
No Bill No. - Insurance network adequacy to avoid "surprise medical bills": Health care coverage for all, administrative simplification.
No Bill No. - AHRQ Center for Primary Care Research: Primary Care research at AHRQ.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Mark |
Cribben |
|
|
|
Teresa |
Baker |
|
House Legislative Assistant, Analyst, and Director |
|
Robert |
Bennett |
|
Health Insurance Specialist , CMS Office of Communication |
|
Sonya |
Clay |
|
Legislative Assistant, Office of U.S. Rep. Jose Serrano; Legislative Assistant, Office of U.S. Rep. Steny Hoyer; Legislative Director, Office of U.S. Rep. Barbara Lee; Legislative Assistant, Office of U.S. Rep.Glen Browder |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code INS
16. Specific lobbying issues
HR 2774 - Primary Care Patient Protection Act: Create a Primary Care benefit in high deductible health plans.
No Bill No. - Administrative Burden: Reduced administrative burden on family physicians.
No Bill No. - Lower Health Care Costs Act/Surprise Billing: Support for vaccines, maternal health, transparency, and reducing administrative burdens. Also, support for reauthorizing the Teaching Health Center GME (THCGME) program, along with Community Health Centers and National Health Service Corps.
No Bill No. - Surprise Billing: Shared letter on surprise billing.
No Bill No. - Insurance network adequacy to avoid "surprise medical bills": Health care coverage for all, administrative simplification.
No Bill No. - Title VII Primary Care training Enhancement Grants: Support for family medicine training.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Mark |
Cribben |
|
|
|
Teresa |
Baker |
|
House Legislative Assistant, Analyst & Director |
|
Sonya |
Clay |
|
Legislative Assistant, Office of U.S. Rep. Jose Serrano; Legislative Assistant, Office of U.S. Rep. Steny Hoyer; Legislative Director, Office of U.S. Rep. Barbara Lee; Legislative Assistant, Office of U.S. Rep.Glen Browder |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TOB
16. Specific lobbying issues
No Bill No. - Flavored e-cigarettes: Support POTUS plan to remove e-cigs from market; Support letter to FLOTUS for bringing up e-cig issue.
17. House(s) of Congress and Federal agencies Check if None
White House Office, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Robert |
Bennett |
|
Health Insurance Specialist, CMS Office of Communication |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MED
16. Specific lobbying issues
HR 2740 - HHS FY 2020 Appropriations; Women's Health Research: AAFP funding priorities. Increased funding for women's health research.
HR 3030 - Patient Centered Outcomes Research Institute reauthorization: Patient-centered, primary care research, AHRQ funding.
No Bill No. - Obesity Drug Study: Responding to GAO inquiry on AAFP policy on obesity drugs.
No Bill No. - Opioid prescribing guideline: Responding to FDA inquiry on opioid prescribing guidelines. Evidence Based opioid prescribing guidelines.
No Bill No. - Opioid Use Disorder Treatment GME: Medication-assisted treatment training.
HR 2328 - Reauthorizing and Extending America's Community Health Act: Support for key primary care extenders, Patient-Centered Outcomes Research Initiative, Independence at Home, Medicaid for the Territories.
No Bill No. - AHRQ Center for Primary Care Research: Primary Care research at AHRQ.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Government Accountability Office (GAO), Food & Drug Administration (FDA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Sonya |
Clay |
|
Legislative Assistant, Office of U.S. Rep. Jose Serrano; Legislative Assistant, Office of U.S. Rep. Steny Hoyer; Legislative Director, Office of U.S. Rep. Barbara Lee; Legislative Assistant, Office of U.S. Rep.Glen Browder |
|
Teresa |
Baker |
|
House Legislative Assistant, Analyst, and Director |
|
Mark |
Cribben |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
HR 2774 - Primary Care Patient Protection Act: Create a Primary Care benefit in high deductible health plans.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Teresa |
Baker |
|
House Legislative Assistant, Analyst and Director |
|
Mark |
Cribben |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code PHA
16. Specific lobbying issues
No Bill No. Office Based physicians compounding drugs: Ability for FPs to compound drugs and not just pharmacists.
17. House(s) of Congress and Federal agencies Check if None
Food & Drug Administration (FDA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Robert |
Bennett |
|
Health Insurance Specialist , CMS Office of Communication |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CSP
16. Specific lobbying issues
No Bill No. - Tobacco Use Prevention: Urged support for reversing the Youth Tobacco Epidemic Act, safe kids act and tobacco to 21 bill.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Sonya |
Clay |
|
Legislative Assistant, Office of U.S. Rep. Jose Serrano; Legislative Assistant, Office of U.S. Rep. Steny Hoyer; Legislative Director, Office of U.S. Rep. Barbara Lee; Legislative Assistant, Office of U.S. Rep.Glen Browder |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code LBR
16. Specific lobbying issues
No Bill No. - Paid Parental Leave: Respond to Senate inquiry.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Teresa |
Baker |
|
House Legislative Assistant, Analyst and Director |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code IMM
16. Specific lobbying issues
HR 2895 - Conrad State 30 & Physician Access Act: Expand J-1 visa waiver program for medical residents.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Mark |
Cribben |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ALC
16. Specific lobbying issues
Urged support for Reversing the Youth Tobacco Epidemic Act, Safe Kids Act, and Tobacco to 21 bill.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, Food & Drug Administration (FDA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Teresa |
Baker |
|
House Legislative Assistant, Analyst and Director |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FOO
16. Specific lobbying issues
No Bill No. Office Based physicians compounding drugs: Ability for FPs to compound drugs and not just pharmacists.
17. House(s) of Congress and Federal agencies Check if None
Food & Drug Administration (FDA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Robert |
Bennett |
|
Health Insurance Specialist , CMS Office of Communication |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code UTI
16. Specific lobbying issues
No. Bill No. - Telehealth for low-income consumers: Access to high speed internet.
17. House(s) of Congress and Federal agencies Check if None
Federal Trade Commission (FTC)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Robert |
Bennett |
|
Health Insurance Specialist, CMS Office of Communication |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
Lobbyist Name | Description of Offense(s) |